eli lilly

Lilly And Ceptyr Announce Drug Discovery Collaboration

Eli Lilly and Company and Ceptyr, Inc., have announced a two-year research collaboration for the discovery of small molecules to treat diabetes, obesity, and impaired glucose tolerance. The collaboration will focus on the phosphatase target, PTP1B, using Ceptyr’s proprietary assays and screening technology. Ceptyr will receive an upfront signing fee, research funding, milestone payments and Read more about Lilly And Ceptyr Announce Drug Discovery Collaboration[…]

eli lilly

Eli Lilly And Reliant Announce Sales And Marketing Agreement

Reliant Pharmaceuticals, LLC, and Eli Lilly and Company announced that Lilly would sell to Reliant the sales and marketing rights for the antiulcer agent Axid in the United States (excluding Puerto Rico). This agreement will help maximize future sales of Axid through expanded sales and marketing efforts and the development of additional formulations by Reliant. Read more about Eli Lilly And Reliant Announce Sales And Marketing Agreement[…]

Ligand Pharmaceuticals

Ligand, Lilly Agree Second Extension To R&D Collaboration

Ligand Pharmaceuticals and Eli Lilly and Company will extend until November 2004 their research collaboration focused on discovering novel drugs for type II diabetes and cardiovascular disorders. This represents the second extension of the collaboration with Lilly, and further strengthens both partners’ confidence in continued success going forward. The Lilly-Ligand collaboration, which began in 1997, Read more about Ligand, Lilly Agree Second Extension To R&D Collaboration[…]

TransForm Pharmaceuticals

TransForm Earns Performance Milestone In Lilly Collaboration

TransForm Pharmaceuticals, Inc. has received a $1 million performance milestone payment from its partner, Eli Lilly and Company, under their collaboration. The performance payment was contingent on TransForm attaining several critical success factors by the end of 2002 as outlined in the agreement. TransForm and Lilly entered into their multi-year collaboration earlier in 2002 to Read more about TransForm Earns Performance Milestone In Lilly Collaboration[…]

eli lilly

Applied Molecular Evolution, Lilly Agree Second Collaboration

Applied Molecular Evolution Inc. (AME) has agreed to optimize an additional therapeutic antibody candidate for Eli Lilly and Co. In December 2001 AME announced its initial collaboration to optimize an antibody and a non-antibody protein therapeutic for Lilly. The goal of the current collaboration is to apply AME‘s proprietary AMEsystem directed molecular evolution technology to Read more about Applied Molecular Evolution, Lilly Agree Second Collaboration[…]

Isis, Lilly Expand Collaboration Into Cancer Drugs

Isis Pharmaceuticals Inc. and Eli Lilly and Co. have expanded their collaboration to develop cancer drugs based on a technology known as antisense. Isis, a small biotechnology company based in Carlsbad, California, and drug giant Lilly, based in Indianapolis, said they had formed a two-year collaboration to discover drugs associated with specific genes that the Read more about Isis, Lilly Expand Collaboration Into Cancer Drugs[…]

Ligand Pharmaceuticals

Ligand And Lilly Advance Novel Drugs

Ligand Pharmaceuticals Incorporated has announced that LY510929, a novel PPAR agonist, and a back-up compound have been declared clinical candidates for development as novel oral treatments for type 2 diabetes and cardiovascular disease. Ligand expects an Investigational New Drug Application (IND) to be filed with the FDA for LY510929 or the back-up compound in the Read more about Ligand And Lilly Advance Novel Drugs[…]

eli lilly

Millennium And Lilly Extend Collaboration

Millennium Pharmaceuticals, Inc. and Eli Lilly and Company have announced a one-year extension of their cardiovascular disease research collaboration. The five-year partnership, originally due to expire in October, will continue at full capacity at least through October of 2001, at which time Lilly has the option to extend for up to two additional years. Since Read more about Millennium And Lilly Extend Collaboration[…]

(R)-Fluoxetine License Agreement To Become Effective

Sepracor Inc. has announced that the Federal Trade Commission (FTC) has closed its investigation, under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, of the license agreement that allows Eli Lilly and Company to exclusively develop and globally commercialize (R) – fluoxetine. (R)-Fluoxetine, a new chemical entity, is a modified form of an active ingredient found in Read more about (R)-Fluoxetine License Agreement To Become Effective[…]

Shop Dragon Pharma Labs Overseas

Sustanon 350 - Discount Price

Administration: Injection
Prime Ingredient: Testosterone Blend
Branded by: Dragon Pharmaceuticals
Package: 30 x 10 mL vial (350 mg/mL)
Price: 30 x $32.00

Masteron 200

Injectable Anabolic Steroid
Principal Component: Drostanolone Enanthate
Manufacturer: Dragon Pharma Labs
Amount: 1 X 10 ml (200 mg/ml)

Sustanon 350 - Cheap Price

Administration: Injection
Prime Ingredient: Testosterone Blend
Manufacturer: Dragon Pharma LLC
Unit: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00

Enanthat 250 [10 Vials]

Injectable Steroid for Muscle Growth
Principal Substance: Testosterone Enanthate
Producer: Dragon Pharma LLC
10 Vials [10 mL per Vial (250 mg/ml)]
Price: 10 x $36.00 = $360.00 in Total

Cut Mix 150

Injectable Steroid for Muscle Growth
Mix of: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (150 mg/mL)

Sustanon 350

Injectable Steroid for Muscle Growth
Mix of: Testosterone Decanoate,
Testosterone Isocaproate, Testosterone PhenylPropionate, Testosterone Propionate
Made by: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (350 mg/mL)

Clomid

Basal Constituent: Clomiphene Citrate
Administration: Oral
Branded by: Dragon Pharmaceuticals
Package: 100 tabs (50 mg/tab)

Masteron 100

Base Component: Drostanolone Di-Propionate
Manufacturer: Dragon Pharma Labs
Package: 10 x 10 mL vial (100 mg/mL)

Deca 500

Primary Chemical Name: Nandrolone Decanoate
Produced by: Dragon Pharma LLC
Pack: 10 mL vial (500 mg/mL)

TriTren 150

Active Chemical Name: Tri Trenbolone
Produced by: Dragon Pharma
Package: 10 mL vial (150 mg/mL)

NPP 150

Main Component: Nandrolone Phenylpropionate
Producer: Dragon Pharma LLC
Amount: 10 mL vial (150 mg/mL)

Nolvadex

Made by: Dragon Pharmaceutical
Principal Ingredient: Tamoxifen Citrate
Package: 100 pills (20 mg/pill)